Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604-Reference-Cited by-同舟云学术

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604

Published:2017-05-26 Issue:1 Volume:17 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Misumi Yuki,Okamoto Hiroaki,Sasaki Jiichiro,Masuda Noriyuki,Ishii Mari,Shimokawa Tsuneo,Hosomi Yukio,Okuma Yusuke,Nagamata Makoto,Ogura Takashi,Kato Terufumi,Sata Masafumi,Otani Sakiko,Takakura Akira,Minato Koichi,Miura Yosuke,Yokoyama Takuma,Takata Saori,Naoki Katsuhiko,Watanabe Koshiro

Funder

none

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3353-y.pdf

Reference34 articles.

1. Toyoda Y, Nakayama T, Ioka A, Tsukuma H. Trends in lung cancer incidence by histological type in Osaka. Japan Jpn J Clin Oncol. 2008;38:534–9.

2. Pallis AG, Shepherd FA, Lacombe D, Gridelli C. Treatment of small-cell lung cancer in elderly patients. Cancer. 2010;116:1192–200.

3. Matsuda A, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2014;44:388–96.